KRM Ayurveda services reach 62.63% of H1 FY27 sales
Key highlights
- KRM Ayurveda services contributed 62.63% of H1 FY27 sales, versus 9.70% in FY24.
- KRM Ayurveda reported H1 FY27 consolidated total income of Rs 68.17 crore, up 40.10% year on year.
- KRM Ayurveda's H1 FY27 EBITDA margin rose to 34.95% from 27.23% in H1 FY26.
- KRM Ayurveda reported eight hospitals, 10 day-care centres and 326 beds as of 30 September 2026.
powered by IRIS

KRM Ayurveda Limited became a services-majority healthcare business in H1 FY27, with services accounting for 62.63% of sales, compared with 9.70% in FY24. KRM Ayurveda reported consolidated total income of Rs 68.17 crore for H1 FY27, up 40.10% year on year, alongside its expanding hospital, day-care and tele-consultancy network.
Know KRM Ayurveda inside out
Results, valuation, peers and who's buying, in one view.
How did KRM Ayurveda's sales mix change?
KRM Ayurveda's sales mix moved decisively towards services, which contributed 62.63% of H1 FY27 sales, while products contributed 37.37%. In FY24, products had represented 90.30% of sales and services only 9.70%, showing that care delivery has become the larger reported sales source over roughly three financial years.
Services first exceeded products in FY26, when they accounted for 53.77% of Rs 101.69 crore in sales, compared with 35.70% in FY25. Service sales increased from Rs 6.52 crore in FY24 to Rs 54.68 crore in FY26; H1 FY27 service sales of Rs 41.95 crore cover only the first six months and are therefore not directly comparable with a full year.
What healthcare network supports KRM Ayurveda's services?
KRM Ayurveda supports service sales through hospitals, day-care centres and tele-consultancy services. As of 30 September 2026, it reported eight hospitals, 10 day-care centres, 326 beds, 60% bed occupancy and five service segments, including inpatient and outpatient care, Panchakarma and wellness, signature therapies, integrative wellness and supportive healthcare.
The company entered the market with Ayurvedic medicine and clinic-based healthcare services in 2019, then established its first Delhi hospital in 2021. It commissioned a second hospital in Gurugram in 2022, launched another hospital in 2024, rolled out three hospitals in 2025 and added a 23-bed New Delhi hospital during 2026.
KRM Ayurveda also identifies digital direct-to-consumer distribution, YouTube educational content, Google and Meta marketing, and tele-consultation with global reach as components of its asset-light operations. Products remain part of the model through its Good Manufacturing Practice-certified Kundli, Haryana facility, which produces classical and proprietary formulations including capsules, tablets, syrups and oil.
Got a follow-up? Ask IRIS
How did KRM Ayurveda's H1 FY27 financial results change?
KRM Ayurveda reported faster growth in earnings before interest, tax, depreciation and amortisation, or EBITDA, and net profit than in consolidated income during H1 FY27. Total income increased 40.10% year on year to Rs 68.17 crore, EBITDA rose 79.81% to Rs 23.82 crore, and net profit increased 109.55% to Rs 17.23 crore.
EBITDA margin rose to 34.95% in H1 FY27 from 27.23% in H1 FY26, an increase of 771.92 basis points, where 100 basis points equal one percentage point. Net profit margin increased to 25.28% from 16.90%, while earnings per share rose to Rs 8.10 from Rs 5.30.
The Q2 FY27 pattern was similar, although margins were below the H1 levels. Q2 total income was Rs 35.30 crore, up 48.08% year on year, EBITDA was Rs 11.26 crore, up 63.60%, and net profit was Rs 8.15 crore, up 95.37%; EBITDA margin was 31.91% and net profit margin was 23.08%.
Management attributed the H1 FY27 result to profitable growth and operational efficiency. Managing Director and Promoter Dr. Puneet Dhawan said the company was pursuing an integrated Ayurvedic healthcare platform combining hospitals, day-care centres, clinical expertise and wellness products.
What expansion is KRM Ayurveda planning and executing?
KRM Ayurveda has board approval for an 80-bed hospital in Sector-47, Gurugram, disclosed on 9 July 2026. The company said the approximately 27,500-square-foot facility would be funded entirely from its own funds, while its existing unit was operating at about 90% to 100% capacity.
The company also disclosed the establishment of MSS Hospital in Pitampura on 16 June 2026, with 23 beds and 5,631 square feet for inpatient and outpatient services. Three Karma Ayurveda day-care centres commenced between April and September 2026: Janakpuri on 10 April, Vashi on 3 September and Ghaziabad on 23 September, with lease terms of nine years, five years and nine years respectively.
KRM Ayurveda disclosed National Accreditation Board for Hospitals and Healthcare Providers, or NABH, accreditation for Panchakarma day-care centres in Lucknow, Noida, Patna and Dwarka, with validity dates ranging from 18 June 2029 to 20 August 2029. Management's H1 FY27 commentary referred to NABH accreditations across five Panchakarma centres, whereas the business-updates page listed four centres.
Management also said the acquisition of Karma Nutravedics marked KRM Ayurveda's entry into nutraceuticals and wellness segments. That development retains a product element within a model where services accounted for Rs 41.95 crore of H1 FY27 sales and products accounted for Rs 25.03 crore.
Conclusion
KRM Ayurveda's reported figures show a substantial reweighting of its business model: services rose from 9.70% of sales in FY24 to 62.63% in H1 FY27, while products fell from 90.30% to 37.37% of the mix. The change coincided with a larger hospital and day-care footprint and H1 FY27 EBITDA of Rs 23.82 crore and net profit of Rs 17.23 crore, both growing faster than total income.
The next disclosed operating milestone is execution of the board-approved 80-bed Sector-47, Gurugram hospital, which KRM Ayurveda plans to fund from its own resources. Investors can also monitor contributions from the 23-bed Pitampura hospital and the three day-care centres opened between April and September 2026, as management pursues its integrated healthcare and wellness platform.


